Breast Clinical Trials in Hangzhou, Zhejiang
61 recruitingHangzhou, Zhejiang, China
Showing 1–20 of 61 trials
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Pfizer400 enrolled371 locationsNCT07062965
Recruiting
Phase 3
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms
Merck Sharp & Dohme LLC2,400 enrolled268 locationsNCT06966700
Recruiting
A Study on Predicting the Risk of Distant Metastasis in Breast Cancer Using AI-Generated Spatial Pathological Maps
Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University400 enrolled4 locationsNCT07244094
Recruiting
Phase 1Phase 2
A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer Stage IV+1 more
Forward Pharmaceuticals Co., Ltd.99 enrolled22 locationsNCT06064812
Recruiting
Phase 1Phase 2
Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy
Breast Adenocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University96 enrolled1 locationNCT06596018
Recruiting
Phase 1Phase 2
Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Breast CancerOvarian CancerProstate Cancer+3 more
Acerand Therapeutics (Shanghai) Limited298 enrolled14 locationsNCT06380660
Recruiting
Not Applicable
Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory Study
Breast Cancer
Tian'an Jiang24 enrolled2 locationsNCT07263451
Recruiting
Phase 2
Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy
Hepatic Artery InfusionLiver Metastasis of Breast Cancer
Zhejiang Cancer Hospital30 enrolled1 locationNCT07284836
Recruiting
Phase 2
A Study of YL202 in Selected Patients With Advanced Solid Tumors
Breast CancerNSCLCHNSCC+1 more
MediLink Therapeutics (Suzhou) Co., Ltd.200 enrolled82 locationsNCT06107686
Recruiting
Phase 1
A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors
Breast CancerLocally Advanced or Metastatic Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.26 enrolled7 locationsNCT05461768
Recruiting
Phase 3
A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)
Locally Advanced or Metastatic Breast Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd.460 enrolled60 locationsNCT06680921
Recruiting
Phase 3
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
Triple Negative Breast Cancer(TNBC)
Biotheus Inc.360 enrolled70 locationsNCT06419621
Recruiting
Not Applicable
Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy
Breast CancerSurgeryLymph Node Metastases
Second Affiliated Hospital, School of Medicine, Zhejiang University126 enrolled1 locationNCT04744506
Recruiting
Not Applicable
Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction
Breast Cancer
Fudan University80 enrolled6 locationsNCT05512286
Recruiting
Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery
Breast CancerMeasurable Residual Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University80 enrolled1 locationNCT06595966
Recruiting
Not Applicable
The Impact of Respiratory Training of DIBH Radiotherapy for Breast Cancer
Breast Cancer
Jianjun Lai80 enrolled1 locationNCT06488391
Recruiting
Phase 3
A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Breast Cancer
Genor Biopharma Co., Ltd.350 enrolled52 locationsNCT05851014
Recruiting
Phase 4
A Study for the Neoadjuvant Treatment of Breast Cancer
Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University1,576 enrolled1 locationNCT05420454
Recruiting
Phase 3
Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University688 enrolled17 locationsNCT02062489
Recruiting
Not Applicable
Prophylactic Irradiation to the Contralateral Breast for BCAs Patients
Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University323 enrolled8 locationsNCT04960839